Celluris
Develops CAR-T immunotherapies (Chimeric Antigen Receptor T‑cell therapy) as immunotherapy-based cancer treatments.
Aims to treat multiple hematological and solid tumor types.
Employees
loading...
Funding Status
loading...
Established
loading...
Total Funding
loading...
ARR
loading...
Insights
Loading Insights...
Loading Insight content to display...
Loading Insights...
Loading Insight content to display...
Founders
loading...
Notable Customers
loading...
Funding
Workforce
Functional Distribution
N/A
Open Positions
N/A
Diversity
N/A
